Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01HD083323)
- National Institutes of Health (R01 HD100812)
- National Institutes of Health (R21 HD102172)
- National Institutes of Health (R01 HD108744)
This publication has 41 references indexed in Scilit:
- Cholesterol Side-Chain Cleavage Gene Expression in Theca Cells: Augmented Transcriptional Regulation and mRNA Stability in Polycystic Ovary SyndromePLOS ONE, 2012
- Genome-wide association study identifies eight new risk loci for polycystic ovary syndromeNature Genetics, 2012
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3Nature Genetics, 2010
- The role of Rab5a GTPase in endocytosis and post-endocytic trafficking of the hCG-human luteinizing hormone receptor complexCellular and Molecular Life Sciences, 2010
- ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cellsOncogene, 2010
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmNature Protocols, 2009
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- The family based association test method: strategies for studying general genotype–phenotype associationsEuropean Journal of Human Genetics, 2001